Please turn JavaScript on
Bariatric News icon

Bariatric News

Receive updates from Bariatric News for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Bariatric News. Unsubscribe at any time.

Site title: Latest | Bariatric News

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.45 / day

Message History

Syntis Bio has announced that results from its Phase 1/1b SYNTIETY-1 trial of SYNT-101, an investigational once-daily tablet for obesity, were presented at The Obesity Society’s 44th Annual Meeting at ObesityWeek® 2026. Data from the trial demonstrated that SYNT-101 reproduced the meal-driven gut-hormone response of gastric bypass surgery, produced placebo-adjusted weight loss o...

Read full story
Amylyx Pharmaceuticals has presented results from the 16-week double-blind treatment period of the Phase 3 LUCIDITY clinical trial of avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist, in participants with post-bariatric hypoglycemia (PBH) following Roux-en-Y gastric bypass (RYGB) surgery, at the ObesityWeek 2026 Annual Meeting. LU...

Read full story
A new diagnostic definition of obesity outperforms body mass index (BMI) in identifying differences in health and prognosis, including mortality risk, according to a large international study led by researchers from King's College London, UK. The research tested the diagnostic framework, ‘Definition and diagnostic criteria of clinical obesity’, proposed by a Lancet Diabetes &...

Read full story
A Cleveland Clinic analysis of more than 20,000 patients, has found that bariatric surgery produced greatest weight loss at two years, followed by switching between GLP-1 medications and switching to a non-GLP1 medication. The findings were presented by the lead author of the study, Dr Hamlet Gasoyan, a researcher with Cleveland Clinic’s Center for Value-Based Care Research, at ...

Read full story
EndoQuest Robotics has announced the successful completion of two robotic transoral gastric reconstruction procedures using the company’s Endoluminal Surgical (ELS) System. Building on the established clinical framework of transoral outlet reduction (TORe), this fully robotic approach uses two-handed instrumentation to precisely perform full-thickness suturing, bringing surgical...

Read full story